Author:
Droogmans Steven,Vanhentenrijk Simon,Cosyns Bernard
Publisher
Springer International Publishing
Reference64 articles.
1. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.
2. Nishimura RA, Vahanian A, Eleid MF, et al. Mitral valve disease—current management and future challenges. Lancet. 2016;387(10025):1324–34.
3. Lavall D, Hagendorff A, Schirmer SH, et al. Mitral valve interventions in heart failure. ESC Heart Fail. 2018;5(4):552–61.
4. Heidbuchel H, Verhamme P, Alings M, et al. Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J. 2017;38(27):2137–49.
5. Lip GYH, Jensen M, Melgaard L, et al. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating ‘valvular heart disease’ in a nationwide cohort study. Europace. 2019;21(1):33–40.